Cargando…
Ion Transport Modulators as Antimycobacterial Agents
There is an urgent need for better and safer therapeutic interventions for tuberculosis (TB). We assessed the effects of FDA-approved ion transport modulators, namely, ambroxol HCl, amiloride HCl, diazoxide, digoxin, furosemide, hydrochlorothiazide (HCTZ), metformin, omeprazole, pantoprazole, phenyt...
Autores principales: | Mitini-Nkhoma, Steven C., Fernando, Narmada, Ishaka, G. K. D., Handunnetti, Shiroma M., Pathirana, Sisira L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700046/ https://www.ncbi.nlm.nih.gov/pubmed/33294223 http://dx.doi.org/10.1155/2020/3767915 |
Ejemplares similares
-
Ion Transport Modulators Differentially Modulate Inflammatory Responses in THP-1-Derived Macrophages
por: Mitini-Nkhoma, Steven C., et al.
Publicado: (2021) -
Strain-Specific Protective Effect of the Immunity Induced by Live Malarial Sporozoites under Chloroquine Cover
por: Wijayalath, Wathsala, et al.
Publicado: (2012) -
Characterization of antigens of Enterobius vermicularis (pinworm) eggs
por: De Kostha, Y. B. N. Sanduni, et al.
Publicado: (2022) -
Strain specific protective immunity induced by pre-erythrocytic infection of toque monkeys with Plasmodium cynomolg
por: Wijayalath, Wathsala, et al.
Publicado: (2010) -
Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents
por: Mitini-Nkhoma, Steven C., et al.
Publicado: (2021)